Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety Use of ATeGe in Liver Transplant Recipients With Pre-transplant Renal Dysfunction (ATG_HVH)

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2014 by Hospital Vall d'Hebron
Sponsor:
Collaborator:
Hospital Universitari Vall d'Hebron Research Institute
Information provided by (Responsible Party):
Cristina Dopazo Taboada, Hospital Vall d'Hebron
ClinicalTrials.gov Identifier:
NCT01453218
First received: October 11, 2011
Last updated: August 14, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2015
  Estimated Primary Completion Date: November 2015 (Final data collection date for primary outcome measure)